ValuEngine Downgrades Q BioMed (OTCMKTS:QBIO) to Hold

Share on StockTwits

Q BioMed (OTCMKTS:QBIO) was downgraded by stock analysts at ValuEngine from a “buy” rating to a “hold” rating in a report released on Thursday, ValuEngine reports.

Separately, Zacks Investment Research upgraded shares of Q BioMed from a “hold” rating to a “buy” rating and set a $2.75 price objective on the stock in a research note on Saturday, January 18th.

QBIO stock opened at $2.51 on Thursday. The firm has a 50 day simple moving average of $2.02 and a 200-day simple moving average of $1.20. The company has a market capitalization of $51.40 million, a P/E ratio of -3.69 and a beta of 5.26. Q BioMed has a twelve month low of $0.34 and a twelve month high of $2.55.

About Q BioMed

Q BioMed Inc, a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89, a radiopharmaceutical therapeutic for the treatment of bone cancer pain therapies. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; BM-001 for the treatment of rare pediatric nonverbal autism spectrum disorder; and Uttroside-B for liver cancer.

Featured Story: What is included in the gross domestic product?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Q BioMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Evergy  Shares Acquired by Bessemer Group Inc.
Evergy Shares Acquired by Bessemer Group Inc.
Nextgen Healthcare Inc  Shares Purchased by Bessemer Group Inc.
Nextgen Healthcare Inc Shares Purchased by Bessemer Group Inc.
Johnson & Johnson  Shares Bought by Bessemer Group Inc.
Johnson & Johnson Shares Bought by Bessemer Group Inc.
Asset Management Corp IL ADV Buys Shares of 22,985 Johnson & Johnson
Asset Management Corp IL ADV Buys Shares of 22,985 Johnson & Johnson
Buckingham Asset Management LLC Raises Position in Johnson & Johnson
Buckingham Asset Management LLC Raises Position in Johnson & Johnson
Microsoft Co.  Shares Sold by Banque Pictet & Cie SA
Microsoft Co. Shares Sold by Banque Pictet & Cie SA


 
© 2006-2020 Zolmax.